PER 3.85% 13.5¢ percheron therapeutics limited

PTC still has DMD drug Emflaza approved and marketed in the US...

  1. 720 Posts.
    lightbulb Created with Sketch. 210
    PTC still has DMD drug Emflaza approved and marketed in the US (3 more years left on Orphan status) as well as other less revenue significant drugs and a sizeable pipeline.

    FDA rejection of Translarna’s NDA application last year wouldn’t have helped though.
    Last edited by BoomCrashOffera: 22/09/23
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
13.5¢
Change
0.005(3.85%)
Mkt cap ! $121.7M
Open High Low Value Volume
13.5¢ 13.5¢ 13.0¢ $378.0K 2.903M

Buyers (Bids)

No. Vol. Price($)
1 5000 13.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 516956 4
View Market Depth
Last trade - 16.10pm 15/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.